These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1402 related articles for article (PubMed ID: 25248005)

  • 1. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
    Iboshi Y; Nakamura K; Fukaura K; Iwasa T; Ogino H; Sumida Y; Ihara E; Akiho H; Harada N; Nakamuta M
    J Gastroenterol; 2017 Mar; 52(3):315-326. PubMed ID: 27178567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
    Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
    Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
    Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R
    Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting T
    Zhou G; Wu W; Yu L; Yu T; Yang W; Wang P; Zhang X; Cong Y; Liu Z
    J Allergy Clin Immunol; 2018 Oct; 142(4):1218-1228.e12. PubMed ID: 29113905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
    Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
    J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease.
    Iboshi Y; Nakamura K; Ihara E; Iwasa T; Akiho H; Harada N; Nakamuta M; Takayanagi R
    Inflamm Bowel Dis; 2014 Jun; 20(6):967-77. PubMed ID: 24739631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.
    He C; Shi Y; Wu R; Sun M; Fang L; Wu W; Liu C; Tang M; Li Z; Wang P; Cong Y; Liu Z
    Gut; 2016 Dec; 65(12):1938-1950. PubMed ID: 26338824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
    Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
    J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
    Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
    Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
    Hovhannisyan Z; Treatman J; Littman DR; Mayer L
    Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17-related cytokines in inflammatory bowel diseases: friends or foes?
    Monteleone I; Sarra M; Pallone F; Monteleone G
    Curr Mol Med; 2012 Jun; 12(5):592-7. PubMed ID: 22515978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.